Health Canada Brand Name Safety Testing
With the release of a guidance from Health Canada (HC) in June 2015 pertaining to preventing medication errors with drug brand names, market authorization holders must now follow a specific process to submit their results to HC for review and approval.
Med-ERRS has developed a service which provides clients with results that meet the guidance criteria. Med-ERRS’ proprietary process corresponds to each part of the guidance from the initial questions to a final report suitable for submission.
Contact us for questions regarding Health Canada Guidance.